menu ☰
menu ˟

VIDEO: Givosiran may ‘transform’ lives of patients with acute hepatic porphyria

20 Apr 2019
VIENNA — In this exclusive video from the 2019 International Liver Congress, Akin Akinc, PhD, of Alnylam Pharmaceuticals, discusses results of a study in which givosiran, a novel RNAi therapy, significantly lowered acute hepatic porphyria recurrent...

Click here to view the full article which appeared in Hepatology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.